People who inject drugs
106 articles
Integrated Hepatitis C Care in Syringe Service Programs Improves Outcomes for People Who Inject Drugs
Tailored models within syringe service programs can overcome barriers and improve HCV cure rates in underserved populations. More
Feasibility of a Prison-Based Test-And-Treat Model for Enhancing Hepatitis C Care in Malaysia
The new prison-based test-and-treat model for HCV infection demonstrates promising feasibility, as indicated by high screening coverage and successful implementation across the HCV care cascade using existing resources. More
Acceptability of Hepatitis C Testing Using Point-Of-Care Testing and Dried Blood Spot Collection Among People at Risk of Hepatitis C Infection
A study evaluated the acceptability of dried blood spot and point-of-care testing among people at risk of HCV infection and examined the circumstances in which such testing is most preferred. More
Impact and Cost-Effectiveness of Scaling up HCV Testing and Treatment Strategies for Achieving HCV Elimination Among People Who Inject Drugs in England: A Mathematical Modelling Study
England aims to reach the WHO elimination target of decreasing HCV incidence among PWID to <2/100pyrs by 2030. A study assessed what testing and treatment strategies will achieve this target and whether they are cost-effective. More
Getting to Full Disclosure: HCV Testing and Status Disclosure Behaviors Among PWID and Their Injecting Partners
The disclosure of HCV status to injecting partners holds significant implications for prevention and care among PWID. More
